Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACI extension study versus microfracture for knee cartilage defects
NL-OMON36244Phase 3Active, not recruiting
- Sponsor
- Sanofi
- Start
- Jun 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous cultured chondrocytes on porcine collagen membrane in cartilage defect of knee, knee injury, sponsored by Sanofi. Started Jun 2011; status: active, not recruiting.
02
Drugs
autologous cultured chondrocytes on porcine collagen membrane
03
Conditions
cartilage defect of kneeknee injury
Beyond the preview
Go deeper on NL-OMON36244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36244.